NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.360
-0.040 (-1.18%)
At close: Aug 12, 2026, 4:00 PM EDT
3.400
+0.040 (1.19%)
After-hours: Aug 12, 2026, 7:14 PM EDT
NRx Pharmaceuticals Revenue
NRx Pharmaceuticals had revenue of $1.07M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $2.29M. In the year 2025, NRx Pharmaceuticals had annual revenue of $1.23M.
Revenue (ttm)
$2.29M
Revenue Growth
n/a
P/S Ratio
61.41
Revenue / Employee
$79,069
Employees
29
Market Cap
140.82M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
NRXP News
- 2 days ago - NRx Pharmaceuticals Transcript: Status update - Transcripts
- 5 days ago - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans - GlobeNewsWire
- 5 days ago - FDA completes review of NRx Pharmaceuticals preservative-free ketamine ANDA - TheFly
- 5 days ago - FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval - GlobeNewsWire
- 6 weeks ago - NRx Pharmaceuticals issues response to Kadima statements - TheFly
- 6 weeks ago - NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute - GlobeNewsWire
- 6 weeks ago - NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System - GlobeNewsWire
- 7 weeks ago - Kadima Neuropsychiatry Institute alleges NRx breached contract - TheFly